Published in Semin Dial on May 19, 2003
Effect of Phosphorus Additives on the Metabolome in Healthy Adults | NCT03841786
Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int (2012) 1.82
Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol (2009) 1.81
Phosphate control in end-stage renal disease: barriers and opportunities. Nephrol Dial Transplant (2013) 1.46
Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol (2010) 1.46
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol (2011) 1.36
Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr (2007) 1.31
Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. J Ren Nutr (2010) 1.18
The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores. J Ren Nutr (2013) 1.07
Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis. Cancer Prev Res (Phila) (2010) 1.07
Public health approach to addressing hyperphosphatemia among dialysis patients. J Ren Nutr (2008) 1.00
Carbonated beverages and chronic kidney disease. Epidemiology (2007) 0.98
Knowledge of phosphorus compared with other nutrients in maintenance dialysis patients. J Ren Nutr (2007) 0.97
Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA). J Ren Nutr (2012) 0.94
Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake. Am J Clin Nutr (2008) 0.94
Mineral metabolic abnormalities and mortality in dialysis patients. Nutrients (2013) 0.93
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. J Am Soc Nephrol (2015) 0.92
Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis (2013) 0.90
Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study. Am J Kidney Dis (2013) 0.87
Increasing dietary phosphorus intake from food additives: potential for negative impact on bone health. Adv Nutr (2014) 0.84
The prevalence and nutritional implications of fast food consumption among patients receiving hemodialysis. J Ren Nutr (2007) 0.83
Estimate of dietary phosphorus intake using 24-h urine collection. J Clin Biochem Nutr (2014) 0.82
The adequacy of phosphorus binder prescriptions among American hemodialysis patients. Ren Fail (2012) 0.81
Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients. Int J Nephrol Renovasc Dis (2014) 0.81
Phosphate: an old bone molecule but new cardiovascular risk factor. Br J Clin Pharmacol (2014) 0.79
Examining the Proportion of Dietary Phosphorus From Plants, Animals, and Food Additives Excreted in Urine. J Ren Nutr (2016) 0.77
Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats. Sci Rep (2016) 0.75
Analysis of a single hemodialysis on phosphate removal of the internal fistula patients by mathematical and statistical methods. Comput Math Methods Med (2013) 0.75
Serum phosphorus levels and risk of incident dementia. PLoS One (2017) 0.75
The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. Biomed Res Int (2017) 0.75
The role of phosphate in kidney disease. Nat Rev Nephrol (2016) 0.75
Socio-Economic Factors, Food Habits and Phosphorus Levels in Patients on Hemodialysis. Nephrourol Mon (2015) 0.75
Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD? Nutrients (2017) 0.75
Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient. CEN Case Rep (2016) 0.75
Contextual poverty, nutrition, and chronic kidney disease. Adv Chronic Kidney Dis (2015) 0.75
Availability of 24-h urine collection method on dietary phosphorus intake estimation. J Clin Biochem Nutr (2016) 0.75
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization. J Clin Endocrinol Metab (2016) 0.75
The New Nordic Diet: phosphorus content and absorption. Eur J Nutr (2015) 0.75
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc (2004) 2.28
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr (2007) 1.56
Venous access: women are equal. Am J Kidney Dis (2003) 1.55
Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab (2009) 1.49
Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. J Steroid Biochem Mol Biol (2010) 1.42
Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes (2005) 1.39
Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med (2008) 1.37
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care (2006) 1.31
Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol (2005) 1.25
Modern India and the vitamin D dilemma: evidence for the need of a national food fortification program. Mol Nutr Food Res (2010) 1.22
Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol (2008) 1.22
Cerebrovascular effects of hemodialysis in chronic kidney disease. J Cereb Blood Flow Metab (2007) 1.17
Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr (2013) 1.14
Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl (2009) 1.13
Contributions to total phosphorus intake: all sources considered. Semin Dial (2012) 1.08
Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clin J Am Soc Nephrol (2012) 1.05
High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation (2004) 1.05
Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis (2004) 1.04
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A (2014) 1.04
Vitamin D intakes in North America and Asia-Pacific countries are not sufficient to prevent vitamin D insufficiency. J Steroid Biochem Mol Biol (2007) 1.04
Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.03
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev (2011) 1.00
Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J Nutr (2005) 0.99
Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol (2006) 0.98
Aging and glycoxidant stress. Hormones (Athens) (2008) 0.94
Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol (2009) 0.92
Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int (2009) 0.92
Glycoxidation and diabetic complications: modern lessons and a warning? Rev Endocr Metab Disord (2004) 0.91
The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep (2004) 0.91
Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? Diabetes Care (2010) 0.90
Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann N Y Acad Sci (2008) 0.89
Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep (2014) 0.89
How should hyperphosphatemia be managed in dialysis patients? Semin Dial (2002) 0.86
Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol (2009) 0.85
Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults? Mol Nutr Food Res (2010) 0.84
Dietary recommendations to meet both endocrine and autocrine needs of Vitamin D. J Steroid Biochem Mol Biol (2005) 0.84
Dietary phosphorus excess: a risk factor in chronic bone, kidney, and cardiovascular disease? Adv Nutr (2013) 0.82
Advanced glycoxidation. A new risk factor for cardiovascular disease? Cardiovasc Toxicol (2002) 0.82
Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury. Rejuvenation Res (2008) 0.82
What unique acid-base considerations exist in dialysis patients? Semin Dial (2004) 0.82
Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol (2006) 0.81
Relation between interdialytic weight gain, body weight and nutrition in hemodialysis patients. Am J Nephrol (2002) 0.81
Potassium balance in dialysis patients. Semin Dial (2013) 0.80
Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression. Virology (2009) 0.80
Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease? Curr Opin Nephrol Hypertens (2014) 0.80
Impact of the surgeon on the prevalence of arteriovenous fistulas. ASAIO J (2002) 0.79
Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci (2008) 0.79
Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients. Am J Nephrol (2006) 0.79
Vitamin D₂ from UVB light exposed mushrooms modulates immune response to LPS in rats. Mol Nutr Food Res (2013) 0.79
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost (2013) 0.78
Effect of exercise on the diameter of arteriovenous fistulae in hemodialysis patients. ASAIO J (2003) 0.78
Dietary phosphorus intake and health1-3. Am J Clin Nutr (2013) 0.78
The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai Hospital. Mt Sinai J Med (2004) 0.78
What can we learn from the saga of chitosan gums in hyperphosphatemia therapy? Clin J Am Soc Nephrol (2014) 0.77
Diet, inflammation, and chronic kidney disease: getting to the heart of the matter. Semin Dial (2008) 0.76
Phosphorus and the kidney: What is known and what is needed. Adv Nutr (2014) 0.76
Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients. Semin Dial (2012) 0.76
Cinacalcet cost and utility in dialysis patients. Semin Dial (2005) 0.75
Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients. Clin Chem Lab Med (2014) 0.75
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children. Horm Res Paediatr (2016) 0.75
Normal homocysteine levels in well-functioning oldest-old individuals despite low kidney function. J Am Geriatr Soc (2006) 0.75
K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications. Semin Dial (2004) 0.75
Introduction to dietary phosphorus excess and health. Ann N Y Acad Sci (2013) 0.75
Unrecognized sources of dietary phosphate. Semin Dial (2002) 0.75
Vitamin D research and public health nutrition: a current perspective. Public Health Nutr (2017) 0.75